New treatment option for Coronary Heart Disease
Official title Effect of Individualized Exercise in Elderly Patients With Coronary Heart Disease
ClinicalTrials.gov ID: NCT06588231
What this study is testing
What is optimal medical therapy :aspirin, clopidogrel, statins.?
optimal medical therapy :aspirin, clopidogrel, statins. is an investigational medicine, being studied as a potential treatment for coronary heart disease.
Also referred to as optimal medical therapy.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The benefits of cardiac rehabilitation have been supported by a large amount of evidence-based medicine. Cardiac rehabilitation can correct cardiovascular risk factors, reduce morbidity and mortality, and improve quality of life.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 60 to 75
You may be able to join if
- Coronary heart disease: coronary angiography confirmed patients with coronary heart disease.
- Age is 60-75 years old, and the clinical sinus rhythm is stable.
- Left ventricular ejection fraction was\> 40%.
- Informed consent and voluntary participation.
You likely can't join if
- Patients with severe organic cardiac and lung diseases.
- Patients with hemiplegia and other physical action disorders.
- A history of mental illness.
- Uncontrolled hypertension, and hemodynamic instability.
- Severe nephropathy and severe peripheral artery disease.
- Patients with bone and joint diseases who are not suitable for exercise.
See the full eligibility criteria
- Coronary heart disease: coronary angiography confirmed patients with coronary heart disease.
- Age is 60-75 years old, and the clinical sinus rhythm is stable.
- Left ventricular ejection fraction was\> 40%.
- Informed consent and voluntary participation.
- Patients with severe organic cardiac and lung diseases.
- Patients with hemiplegia and other physical action disorders.
- A history of mental illness.
- Uncontrolled hypertension, and hemodynamic instability.
- Severe nephropathy and severe peripheral artery disease.
- Patients with bone and joint diseases who are not suitable for exercise.
- Uncontrolled endocrine system and other diseases.
- Antibiotics and anti-diarrheal medications have not been used for at least 3 months.
The study team makes the final eligibility decision.
Where it's taking place
- Nanjing, Jiangsu, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 60 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Nanjing, Jiangsu, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.